NYSE:NOC • US6668071029
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NORTHROP GRUMMAN CORP (NOC).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-02 | Jefferies | Maintains | Hold -> Hold |
| 2026-01-28 | BTIG | Maintains | Buy -> Buy |
| 2026-01-28 | UBS | Maintains | Buy -> Buy |
| 2026-01-28 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-01-28 | B of A Securities | Maintains | Buy -> Buy |
| 2026-01-28 | Citigroup | Maintains | Buy -> Buy |
| 2026-01-15 | UBS | Maintains | Buy -> Buy |
| 2026-01-13 | Citigroup | Maintains | Buy -> Buy |
| 2026-01-09 | Truist Securities | Downgrade | Buy -> Hold |
| 2025-12-15 | Alembic Global | Upgrade | Neutral -> Overweight |
| 2025-12-12 | Citigroup | Initiate | Buy |
| 2025-10-23 | Bernstein | Maintains | Market Perform -> Market Perform |
| 2025-10-22 | BTIG | Maintains | Buy -> Buy |
| 2025-10-22 | UBS | Maintains | Buy -> Buy |
| 2025-10-22 | Susquehanna | Maintains | Positive -> Positive |
| 2025-10-22 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-20 | Bernstein | Maintains | Market Perform -> Market Perform |
| 2025-10-15 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-15 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-08 | Deutsche Bank | Upgrade | Hold -> Buy |
| 2025-07-29 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-23 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-23 | Susquehanna | Maintains | Positive -> Positive |
| 2025-07-23 | Truist Securities | Reiterate | Buy -> Buy |
| 2025-07-23 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 39.29B 7.34% | 41.033B 4.44% | 41.954B 2.24% | 44.305B 5.60% | 46.983B 6.04% | 49.465B 5.28% | 51.878B 4.88% | 54.846B 5.72% | 51.708B -5.72% | 53.258B 3.00% | |
| EBITDA YoY % growth | 3.875B -21.61% | 5.74B 48.13% | 5.752B 0.21% | 6.292B 9.39% | 6.721B 6.82% | 7.066B 5.13% | 7.324B 3.65% | 7.531B 2.83% | N/A | N/A | |
| EBIT YoY % growth | 2.537B -29.55% | 4.37B 72.25% | 4.28B -2.06% | 4.697B 9.74% | 5.075B 8.05% | 5.446B 7.31% | 5.837B 7.18% | 6.292B 7.80% | N/A | N/A | |
| Operating Margin | 6.46% | 10.65% | 10.20% | 10.60% | 10.80% | 11.01% | 11.25% | 11.47% | N/A | N/A | |
| EPS YoY % growth | 23.29 -10.01% | 26.07 11.94% | 28.07 7.67% | 28.27 0.70% | 30.24 6.98% | 32.67 8.03% | 34.47 5.52% | 36.87 6.96% | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 6.06 0.05% | 6.92 -2.65% | 7.36 -4.08% | 8.28 14.52% | 7.13 17.61% | 7.77 12.21% | 7.86 6.87% | 8.74 5.52% |
| Revenue Q2Q % growth | 9.825B 3.77% | 10.88B 5.11% | 11.116B 6.65% | 12.278B 4.83% | 10.663B 8.53% | 11.629B 6.88% | 11.681B 5.08% | 12.994B 5.83% |
| EBITDA Q2Q % growth | 1.385B 52.20% | 1.546B -17.81% | 1.624B -29.64% | 1.801B -34.34% | 1.514B 9.31% | 1.679B 8.60% | 1.689B 4.00% | 1.893B 5.11% |
| EBIT Q2Q % growth | 1.013B 76.79% | 1.154B -3.35% | 1.237B -0.40% | 1.377B 8.34% | 1.174B 15.89% | 1.292B 11.96% | 1.301B 5.17% | 1.446B 5.01% |
All data in USD
28 analysts have analysed NOC and the average price target is 744.59 USD. This implies a price decrease of -0.37% is expected in the next year compared to the current price of 747.34.
NORTHROP GRUMMAN CORP (NOC) will report earnings on 2026-04-20, before the market open.
The consensus EPS estimate for the next earnings of NORTHROP GRUMMAN CORP (NOC) is 6.06 USD and the consensus revenue estimate is 9.82B USD.
The number of analysts covering NORTHROP GRUMMAN CORP (NOC) is 28.